XML 56 R42.htm IDEA: XBRL DOCUMENT
v3.26.1

SEGMENT INFORMATION (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2026
Segment Reporting [Abstract] |
Schedule of Reconciliation of Significant Expense Categories | The table below reconciles the significant expense categories provided to the CODM to the Company’s expenses as disclosed under GAAP (in thousands):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Revenues | $ | 192,399 |  |  | $ | 181,099 |  |  | $ | 369,775 |  |  | $ | 350,022 |
Less: |  |  |  |  |  |  |
Adjusted cost of goods sold (1) | 42,355 |  |  | 32,663 |  |  | 77,125 |  |  | 65,253 |
Adjusted research and development (1) | 27,053 |  |  | 24,686 |  |  | 52,415 |  |  | 47,787 |
Adjusted selling and marketing (1) | 52,117 |  |  | 50,964 |  |  | 110,283 |  |  | 106,535 |
Adjusted general and administrative (1) | 29,148 |  |  | 26,231 |  |  | 54,860 |  |  | 46,840 |
Stock-based compensation (1) | 14,958 |  |  | 15,472 |  |  | 28,497 |  |  | 30,025 |
Amortization of acquired intangible assets | 14,322 |  |  | 14,322 |  |  | 28,644 |  |  | 28,644 |
Divestiture and acquisition-related expenses (2) | 6,516 |  |  | 2,098 |  |  | 7,396 |  |  | 3,960 |
Changes in the fair value of contingent consideration | 1,663 |  |  | (357) |  |  | (614) |  |  | (3,032) |
Legal settlement | — |  |  | — |  |  | — |  |  | 7,000 |
Decommissioning of manufacturing suite | — |  |  | 6,521 |  |  | — |  |  | 6,521 |
Total operating expenses | 188,132 |  |  | 172,600 |  |  | 358,606 |  |  | 339,533 |
Total other expense, net | (1,712) |  |  | (10,426) |  |  | (3,616) |  |  | (3,710) |
Income (loss) before income taxes | 2,555 |  |  | (1,927) |  |  | 7,553 |  |  | 6,779 |
Income tax benefit (expense) | 2,098 |  |  | (2,920) |  |  | 16 |  |  | (6,814) |
Net income (loss) | $ | 4,653 |  |  | $ | (4,847) |  |  | $ | 7,569 |  |  | $ | (35) |
(1) The adjustments are primarily related to stock-based compensation being noted separately as a line item. (2) During the three and six months ended June 30, 2026, the Company recognized $5.9 million of divestiture-related expenses, primarily related to third-party services and legal fees, which were recorded to other operating expenses, net in the condensed consolidated statement of operations. In February 2025, the Company acquired the remaining 81% of GQ Bio that it did not already own. During the three and six months ended June 30, 2025, the Company incurred acquisition-related expenses of $1.0 million and $2.5 million, respectively, mainly related to third-party services and legal fees associated with the acquisition of GQ Bio, which were recorded to other operating expenses, net in the condensed consolidated statement of operations. As part of the purchase agreement, $7.8 million of expense will be recognized and paid over three years pursuant to a key employee holdback agreement in increments of 50%, 30% and 20%, respectively. This resulted in $0.6 million and $1.5 million recognized within research and development in the condensed consolidated statement of operations for the three and six months ended June 30, 2026, respectively, and $1.1 million and $1.5 million for the three and six months ended June 30, 2025, respectively.

X
- Definition Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration